UNSPSC 51393302: Benafentrine
Commodity
Code facts
- Part of
-
-
51000000
-
51390000
- 51393300
-
51390000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51393302
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a phosphodiesterase inhibitor with the molecular formula C23H27N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DXB7KMD1F, chemically known as 4-(1,2,3,4,4qbeta,10bbeta-hexahydro-8,9-dimethoxy-2-methylbenzo(c)(1,6)naphthyridin-6-yl)acetanilid but generally known as benafentrine, which bears US NIH Compound Identifier 3084603. European Medicines Agency schedules Benafentrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05697MIG.
Read the full definition
The term BENAFENTRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). BENAFENTRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benafentrine under HS 29339990 and SITC 51577. As of Q4 2014, BENAFENTRINE remains the US FDA Preferred Term for this commodity. Benafentrine bears US NLM identifiers UMLS ID C0050999 and NCI Concept Code C74346. SMILES: O(C1CC2C3C(N=C(C2CC1OC)C1CCC(NC(=O)C)CC1)CCN(C3)C)C.
About UNSPSC 51393302
UNSPSC 51393302 Benafentrine is a Commodity code that in recent state and local procurement activity encompasses opioid antagonists and related pharmaceutical products used in community health and overdose-response programs. The code appears in solicitations for naloxone procurement by county health departments and similar public-health agencies that support emergency medical services and harm-reduction initiatives. Issuing bodies soliciting under this code include county health administrations and local public-health departments seeking to stock naloxone and complementary drug-deactivation systems for community distribution or clinical use.
Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2023, for 1,900 units of naloxone and 800 safe drug-deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation required electronic bid submission through the county's e-Procurement Portal, unit pricing for each line item, E-Verify compliance, and drug-free workplace certification. The contract was structured as a fixed-fee, two-year initial term with a one-year renewal option and carried potential FEMA funding with associated federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. Recent state and local opportunities under this code remain limited; this represents a singular visible active solicitation in the recent record.
Quick answers
What is UNSPSC 51393302?
UNSPSC 51393302 is Benafentrine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51393302?
UNSPSC 51393302 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51393302
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code